2-(2,6-DIOXOPIPERIDIN-3-YL)-5-HYDROXYISOINDOLINE-1,3-DIONE, 95%, 10g

Methyl 2-((tert-butoxycarbonyl)amino)-3-iodopropanoate, 95.0%, 25g

4-Nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97%, 5g

4-(4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)benzene-1,3-diol, 95.0%, 50g

4-(2H-Tetrazol-5-yl)-benzaldehyde, 95.0%, 1g

N-Carbobenzoxy-6-aminohexanoic Acid>98.0%(HPLC)(T)25g

Fmoc-S-acetamidomethyl-L-homocysteine, 25mg

2,6-Dichloro-N-methylpyrimidin-4-amine, 95.0%, 100mg

3-Methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine, 98.0%, 1g

Chlorure de fer(III) hexahydraté, min 99 %, pa, 250 g, emballage plastique.

1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 97.0%, 100mg

1-(2-Chlorophenyl)-3-phenyl-2-thiourea, 95+%, 250mg

tert-Butyl (4-chlorobutyl)carbamate, 95.0%, 5g